Clinical Trials Directory

Trials / Terminated

TerminatedNCT01406795

The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses

Evaluation of GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface for the Treatment of Venous Occlusions and Stenoses

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although performed by some practitioners, has not yet been studied in detail.

Conditions

Interventions

TypeNameDescription
DEVICEGore Viabahn Heparin Coated StentFor subjects deemed to be suffering from chronic venous insufficiency of the femoral or popliteal veins, a Gore Viabahn stent will be implanted during a venoplasty procedure to determine whether the vein will stay open.

Timeline

Start date
2010-12-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2011-08-01
Last updated
2017-02-27
Results posted
2017-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01406795. Inclusion in this directory is not an endorsement.

The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses (NCT01406795) · Clinical Trials Directory